In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Altimmune Inc (NASDAQ: ALT) closed at $3.5 down -3.05% from its previous closing price of $3.61. In other words, the price has decreased by -$3.05 from its previous closing price. On the day, 19.8 million shares were traded. ALT stock price reached its highest trading level at $3.77 during the session, while it also had its lowest trading level at $3.38.
Ratios:
For a deeper understanding of Altimmune Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.82 and its Current Ratio is at 15.82. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On January 08, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $18.
On November 12, 2024, UBS started tracking the stock assigning a Buy rating and target price of $26.UBS initiated its Buy rating on November 12, 2024, with a $26 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 17 ’25 when Sohn Catherine A. bought 1,000 shares for $5.78 per share. The transaction valued at 5,784 led to the insider holds 1,000 shares of the business.
WEAVER GREGORY L bought 10,000 shares of ALT for $51,996 on Mar 13 ’25. The Chief Financial Officer now owns 10,000 shares after completing the transaction at $5.20 per share. On Aug 19 ’24, another insider, Drutz David, who serves as the Director of the company, sold 16,011 shares for $6.90 each. As a result, the insider received 110,547 and left with 41,958 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALT now has a Market Capitalization of 283874496 and an Enterprise Value of 135635408. For the stock, the TTM Price-to-Sale (P/S) ratio is 14193.50 while its Price-to-Book (P/B) ratio in mrq is 1.92. Its current Enterprise Value per Revenue stands at 6781.77 whereas that against EBITDA is -1.384.
Stock Price History:
The Beta on a monthly basis for ALT is 0.49, which has changed by -0.5138889 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, ALT has reached a high of $11.16, while it has fallen to a 52-week low of $2.90. The 50-Day Moving Average of the stock is -38.34%, while the 200-Day Moving Average is calculated to be -46.50%.
Shares Statistics:
For the past three months, ALT has traded an average of 4.23M shares per day and 14756810 over the past ten days. A total of 81.11M shares are outstanding, with a floating share count of 80.26M. Insiders hold about 1.04% of the company’s shares, while institutions hold 47.38% stake in the company. Shares short for ALT as of 1749772800 were 24400612 with a Short Ratio of 5.77, compared to 1747267200 on 22671188. Therefore, it implies a Short% of Shares Outstanding of 24400612 and a Short% of Float of 30.320000000000004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
